Alerion Taps New CEO to Unify Fragmented Health Plan Services

NEW YORK, NY – May 05, 2026 – Alerion Advisors has appointed veteran healthcare executive Jason Montrie as its new Chief Executive Officer, a strategic move aimed at accelerating the company’s mission to build a unified service and technology platform for beleaguered health plans. The appointment signals a new chapter for Alerion and its private equity backers as they seek to solve the growing operational complexities facing the healthcare industry.

Montrie will take the helm of Alerion and its portfolio of specialized companies—Toney Healthcare, Advent Advisory Group, and Rebellis Group—tasked with integrating their distinct capabilities and driving an aggressive growth strategy.

A Proven Operator for a Complex Market

With over 25 years of experience spanning health plan operations, technology, and clinical services, Jason Montrie brings a deep understanding of the challenges Alerion aims to solve. His career includes senior leadership roles where he was responsible for driving growth and operational scale. Most recently, he served as Executive Vice President at NationsBenefits, a provider of supplemental benefits. He also co-founded and served as CEO of Land of Lincoln Health, an Illinois-based health insurance co-op born from the Affordable Care Act.

While Land of Lincoln Health ultimately ceased operations in 2016 amid widespread financial challenges that affected many co-ops, Montrie’s tenure there provided him with firsthand experience in navigating the intense regulatory and financial pressures that health plans face. This experience is complemented by leadership positions at data analytics firm Pareto Intelligence and healthcare technology provider Convey Health.

This unique background is precisely what Alerion’s investors were seeking. "Jason brings a unique combination of strategic vision and operational leadership," said Daniel Brinkenhoff, Managing Director at Centre Partners, one of the private equity firms backing Alerion. "His experience founding and leading healthcare companies—and his deep knowledge of how health plans operate, compete and grow—makes him exactly the right leader to accelerate Alerion's platform vision."

The "Integrated Platform" Gambit

Alerion Advisors is betting that the future of health plan support lies not in siloed consultants but in a single, integrated partner. The company's core strategy is to bundle a comprehensive suite of services that are traditionally sourced from multiple, disparate vendors. This "one-stop-shop" model is built upon its family of companies:
* Toney Healthcare: Provides critical clinical staffing and utilization management services, addressing workforce shortages and operational efficiency.
* Advent Advisory Group: Focuses on HEDIS auditing and quality programs, helping plans improve performance on crucial metrics.
* Rebellis Group: Specializes in government program compliance and strategy, guiding plans through the labyrinth of federal regulations.

By uniting these capabilities, Alerion aims to offer a seamless solution for health plans across Medicare Advantage, Medicaid, TRICARE, and Commercial markets. The goal is to move clients "seamlessly from insight to execution," eliminating the friction and inefficiency of managing multiple service partners.

"Alerion Advisors is building something that hasn't existed in this market before—a fully integrated platform that brings together clinical depth, compliance rigor, strategic advisory and operational execution," Montrie stated in the announcement. He emphasized that health plans need partners who can both devise strategy and execute it, a core tenet of Alerion's value proposition.

Addressing an Industry at an Inflection Point

Montrie’s appointment comes at a critical time for the U.S. healthcare industry. Health plans are navigating what Alerion board member Scott Whyte calls "an environment of extraordinary complexity." The primary pressures include tightening financial margins, a relentless pace of regulatory changes from the Centers for Medicare & Medicaid Services (CMS), and persistent workforce shortages.

For Medicare Advantage plans in particular, evolving Star Ratings methodologies and increased scrutiny on risk adjustment and marketing practices have raised the stakes for compliance and quality performance. Simultaneously, rising medical costs and competitive premium pressures are squeezing profitability. Health plans are also struggling to recruit and retain the clinical and administrative staff needed to manage core functions like utilization review and care management.

It is this convergence of challenges that forms the bedrock of Alerion’s business case. The company positions itself as an essential partner for organizations that lack the internal resources or specialized expertise to manage these pressures alone. "What separates organizations that thrive from those that struggle is access to genuine domain expertise, paired with robust service capabilities and the right technology infrastructure," noted Whyte, who is also a Partner at Health Enterprise Partners (HEP). "Alerion is building exactly that platform, and Jason is the leader who knows how to scale it."

The Private Equity Growth Engine

The strategic direction of Alerion is heavily influenced by its ownership. The company is backed by two private equity firms: Centre Partners, a middle-market investor with a diverse portfolio, and Health Enterprise Partners (HEP), a specialist firm focused exclusively on healthcare services and technology companies.

The involvement of HEP, in particular, underscores the strategy. HEP’s investment thesis centers on funding companies that can reduce healthcare costs or improve quality, and its portfolio is filled with technology-enabled service providers. This backing provides Alerion not only with capital but also with deep industry expertise and a network to fuel its growth.

Industry analysts expect this PE backing to translate into an aggressive growth trajectory for Alerion, likely involving both organic expansion and strategic "add-on" acquisitions. Montrie, with his experience in scaling operations, will be expected to identify and integrate new companies that can either deepen Alerion's existing capabilities or add new service lines to the platform. This buy-and-build strategy is a common playbook for PE firms looking to create a market leader in a fragmented industry.

As Montrie takes the reins, his challenge will be to weave the disparate threads of Alerion's companies into a single, cohesive tapestry. If successful, the company could redefine how health plans approach operational management and strategic growth in an increasingly demanding market.